Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Sutro Biopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for STRO.
You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.
Other companies in Sutro Biopharma’s space includes: Adaptimmune Therapeutics (NASDAQ:ADAP), Fate Therapeutics (NASDAQ:FATE), Kyverna Therapeutics (NASDAQ:KYTX), Genelux (NASDAQ:GNLX) and TScan Therapeutics (NASDAQ:TCRX).
Sutro Biopharma has a consensus price target of $11.22.
The stock price for Sutro Biopharma (NASDAQ: STRO) is $1.52 last updated March 4, 2025 at 7:06 AM EST.
There are no upcoming dividends for Sutro Biopharma.
Sutro Biopharma’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Sutro Biopharma.
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.